Our Team

Jared LynchTechnology Editor

Jared Lynch is The Australian’s Technology Editor, with a career spanning two decades. Jared is based in Melbourne and has extensive experience in markets, start-ups, media and corporate affairs. His work has gained recognition as a finalist in the Walkley and Quill awards. Previously, he worked at The Australian Financial Review, The Sydney Morning Herald and The Age.

@jaredm_lynch

Latest

UpdatedCompanies

Bubs Australia's goat milk infant formula. Picture: PETER HEMPHILL

Bubs’ plan to sidestep any China ban

Bubs is set to manufacture goat’s milk infant formula in China, amid Beijing’s growing hostility towards Australian products.

Jared Lynch

Health insuranceCompanies

AMP's Acting CEO Mike Wilkins reads a statement to the media after leaving the Banking Royal Commission into Misconduct in the Banking, Superannuation and Financial Services Industry in Melbourne, Wednesday, November 28, 2018. (AAP Image/Wayne Taylor) NO ARCHIVING

Medibank names new chair, profit sinks 31pc

Medibank says expected COVID-19 savings have failed to eventuate, as the health insurer announced a change at the top.

Jared Lynch

CoronavirusNation

SYDNEY, AUSTRALIA - AUGUST 19: Prime Minister Scott Morrison is seen wearing a face mask during a press conference at AstraZeneca on August 19, 2020 in Sydney, Australia. The Australian government has announced an agreement with the British pharmaceutical giant AstraZeneca to secure at least 25 million doses of a COVID-19 vaccine if it passes clinical trials. The University of Oxford COVID-19 vaccine is currently in phase-three testing. If the vaccine proves to be successful, Australia will manufacture and supply vaccines and will be made available for free. The project could deliver the first vaccines by the end of this year or by early 2021. (Photo by Lisa Maree Williams/Getty Images)

Months left in race to vaccine

Scott Morrison has foreshadowed jabs for healthcare workers and the elderly as soon as early next year.

Natasha Robinson and Jared Lynch

UpdatedCompanies

12/02/2020: CSL CEO Paul Perreault, at the company's Parkville head office. Stuart McEvoy/The Australian.

CSL narrows in on three potential COVID-19 vaccines

While optimistic, CSL says multiple vaccines will be needed to quash the coronavirus pandemic, as its lifted annual profit 9.6pc.

Jared Lynch

CoronavirusNation

injecting injection vaccine vaccination medicine flu man doctor insulin health drug influenza concept - stock image

CSL push for vaccine within a year

‘Emergency doses’ of a COVID-19 vaccine could be delivered by the middle of next year after CSL tightened its development timeline.

Jared Lynch

DairyBusiness

a2 skim milk powder. Picture: PETER HEMPHILL

A2 Milk buys Victorian dairy, profit surges

A2 Milk has opened its chequebook to strengthen its manufacturing capability, as annual profit jumped by one third.

Jared Lynch

BiotechCompanies

17-08-17 - Cochlear CEO Dig Howitt at Cochlear facility in Macquarie Park. This is his first first annual results since taking the top job. Ryan Osland/ The Australian.

Cochlear swings to loss on court costs and Covid

Hearing implant maker Cochlear has posted a $238.3m loss after elective surgery cancellations and US litigation expenses wiped out profits.

Jared Lynch and SAMANTHA BAILEY

Aged careCompanies

Cleaners are seen entering the Estia Health aged care facility in Ardeer where there has been an outbreak of COVID-19. Wednesday, July 29, 2020. Picture: David Crosling

Estia reels from Victoria’s Covid wave

Estia’s Victorian nursing homes are under strict controls after a third were infected with COVID, fuelling $144m in writedowns.

Jared Lynch

COMPANIESCompanies

A2 Milk the Dyson of dairy

A conga-line of copycats are looking to lap up A2 Milk’s cream, but chairman David Hearn has declared the company can become the Dyson of dairy.

Jared Lynch

EXCLUSIVECompanies

A scientist works at the mAbxience biosimilar monoclonal antibody laboratory plant in Garin, Buenos Aires province, on August 14, 2020, where an experimental coronavirus vaccine will be produced for Latin America. - Argentina will manufacture while Mexico will pack and distribute in Latin America, except of Brazil, the vaccine against COVID-19 developed by the University of Oxford and the AstraZeneca laboratory. (Photo by JUAN MABROMATA / AFP)

CSL in vaccine talks with AstraZeneca

CSL confirms it is in talks with British pharmaceutical giant AstraZeneca about producing its vaccine in Melbourne.

Jared Lynch

Original URL: https://www.theaustralian.com.au/author/jared-lynch/page/200